REACT 2021 EMPOWERING CLINICIANS TO ADVANCE CANCER CARE

At REACT 2021, we will highlight the latest advances in the treatment and diagnosis of common malignancies, such as prostate, urologic, hematologic, gynecologic, and gastrointestinal cancers, while fostering new collaborations with colleagues from across the globe.

Following our motto, “hope without boundaries”, Sheba Medical Center, a global leader in medical innovation ranked as one of the top 10 hospitals globally by Newsweek, created REACT 2021 to empower healthcare professionals around the world. By providing the resources needed to offer patients the latest diagnostic tools and treatments, we aim to impact healthcare on a global level.

Alt

ON BEHALF OF SHEBA MEDICAL CENTER AND ALL OF ITS DEDICATED CLINICIANS AND HEALTH PROFESSIONALS,

WELCOME TO REACT 2021, AND LET’S ADVANCE CANCER CARE TOGETHER!

AGENDA What's this about?

Following opening remarks and short introductory presentations by each speaker, six separate lectures and Q&A sessions will take place in breakout rooms.

13:00-13:05

Opening Remarks

Ms. Cohen Herszaft will launch the event, welcoming all participants and providing a short introduction to Sheba Medical Center and REACT 2021.
Vered Cohen Herszaf Director of Global Patient Services at Sheba Medical Center  
13:05-13:13

The Role of Immunotherapy in Cancer Therapy

In a short introductory lecture, Prof. Nagler will outline the role and benefits of immunotherapy as part of cancer treatment. For more on the latest advances in hematological immunotherapies, please join Prof. Nagler in breakout room 2 after the remaining introductions.
Prof. Arnon Nagler President of the Hemato-Oncology Center, Sheba Medical Center  
13:13-13:21

Combined Modality Therapy in the Operating Theater

In a short introductory lecture, Dr. Ben Yaacov will discuss the benefits and implications of combined modality therapy in the operating theater. Please join Dr. Ben Yaacov in breakout room 4 after the remaining introductions to learn more about the latest advances in peritoneal surface malignancy management.
Dr. Almog Ben Yaacov Attending Surgical Oncologist & Head of the Residency Training Program at the Department of Surgery and Surgical Oncology (Surgery C)  
13:21-13:29

Oligometastatic Cancer – A New Treatment Paradigm: Ultra-Short Precise Radiotherapy

In a short introductory lecture, Prof. Symon will outline recent innovations in oligo-metastatic cancer radiotherapy. For more on the latest advances in precise radiotherapy, please join Prof. Symon in breakout room 1 after the remaining introductions.
Prof. Zvi Symon Director of the Radiation Oncology Institute, Sheba Medical Center  
13:29-13:37

Breakthroughs in Targeted Therapy for Ovarian Cancer

In a short introductory lecture, Dr. Helpman will outline the latest developments in ovarian cancer targeted therapy. For more on advances in gynecologic cancer treatment, please join Dr. Helpman after the remaining introductions in breakout room 6.
Dr. Limor Helpman Deputy Director of the Gynecologic Oncology Department, Sheba Medical Center  
13:37-13:45

Uro-Oncology Progress in the Last Decade

In a short introductory lecture, Dr. Dotan will present a short overview of uro-oncology's progress over the past decade. Please join Dr. Dotan in breakout room 5 after the remaining introduction to learn more about the benefits of robotic surgery for urological malignancies.
Dr. Zohar Dotan Director of the Department of Urology and Uro-Oncology Service, Sheba Medical Center  
13:45-13:53

The Gold Standard Treatment for Melanoma in 2021

In a short introductory lecture, Dr. Asher will outline the ‘gold standard’ of modern melanoma treatment. For more on the latest advances in melanoma treatment, please join Dr. Asher in breakout room 3 after his lecture.
Dr. Nethanel (Nati) Asher Senior Physician at the Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center  
13:53-14:23

Implementation of New Technologies for Radical Prostate Cancer Radiation Therapy

The lecture will start with a review of the Sheba Radiotherapy Center’s extensive experience in treating prostate cancer patients, followed by an exploration of the latest technological innovations in prostate cancer radiotherapy. Treatments to be discussed include MRI/TRUS-guided brachytherapy, SMART SEED therapy, and SBRT treatment with a spacer.
Prof. Zvi Symon Director of the Radiation Oncology Institute, Sheba Medical Center  
14:23-14:38

Q&A Session

During the Q&A session, participants will be able to ask Prof. Symon any questions they may have concerning his lecture or other clinical issues.
Prof. Zvi Symon Director of the Radiation Oncology Institute, Sheba Medical Center  
13:53-14:23

Cellular and Humoral Immunotherapy for Hematological Malignancies

During his lecture, Prof. Nagler will expand on the latest hematological immunotherapies. New cell-based gene treatments, such as CAR T-cell therapy, and advanced drug conjugated and bispecific monoclonal antibodies, will be discussed.
Prof. Arnon Nagler President of the Hemato-Oncology Center, Sheba Medical Center  
14:23-14:38

Q&A Session

During the Q&A session, participants will be able to ask Prof. Nagler any question they may have concerning his lecture or other clinical issues.
Prof. Arnon Nagler President of the Hemato-Oncology Center, Sheba Medical Center  
13:53-14:23

Advanced Lines and Innovations in the Field of Melanoma: What Else Is Out There?

During his lecture, Dr. Asher will provide an overview of advanced melanoma treatments based on global studies and the rich experience accumulated at Sheba’s Ella Institute for the Treatment and Research of Melanoma. Dr. Asher will discuss the options available for refractory patients when standard treatments are no longer effective, and current breakthrough therapies whose application is spearheaded by Sheba researchers, such as fecal microbiota transplantation, advanced cell therapies, and immuno-apheresis. Long-term results of the aforementioned advanced treatments will be presented during the lecture.
Dr. Nethanel (Nati) Asher Senior Physician at the Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center  
14:23-14:38

Q&A Session

During the Q&A session, participants will be able to ask Dr. Asher any questions they may have concerning his lecture or other clinical issues.
Dr. Nethanel (Nati) Asher Senior Physician at the Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center  
13:53-14:23

Management of Peritoneal Surface Malignancies

Most cancers involving the peritoneum metastasize from colorectal, appendiceal, ovarian, pancreatic, gastric, and other abdominal cancers. Peritoneal surface malignancies (PSMs) can be very difficult to treat, and until recently were considered an incurable disease when occurring as metastasis. Join Dr. Ben Yaacov as he explores the paradigm shift in PSM treatment from palliation into a new era of radical surgery combined with heated chemotherapy (HIPEC): offering long-term survival (cure) or prolonged disease-free survival for most patients and providing many with new hope.
Dr. Almog Ben Yaacov Attending Surgical Oncologist & Head of the Residency Training Program at the Department of Surgery and Surgical Oncology (Surgery C)  
14:23-14:38

Q&A Session

During the Q&A session, participants will be able to ask Dr. Ben Yaacov any questions they may have concerning his lecture or other clinical issues.
Dr. Almog Ben Yaacov Attending Surgical Oncologist & Head of the Residency Training Program at the Department of Surgery and Surgical Oncology (Surgery C)  
13:53-14:23

Robotic Surgery for Urological Malignancies

Since the early 2000s, surgical treatment of urological malignancies has moved towards minimally invasive approaches. In recent years, advanced robotic surgical systems, which can offer significantly shorter recovery times for patients, have also become prevalent in leading medical institutions. Join Dr. Dotan as he explores the latest advances in minimally invasive urological surgery, highlighting treatment procedures at a global leader in the field: Sheba Medical Center’s Department of Urology.
Dr. Zohar Dotan Director of Urology Department and Uro-Oncology Service, Sheba Medical Center  
14:23-14:38

Q&A Session

During the Q&A session, participants will be able to ask Dr. Dotan any questions they may have concerning his lecture or other clinical issues.
Dr. Zohar Dotan Director of Urology Department and Uro-Oncology Service, Sheba Medical Center  
13:53-14:23

The Impact of Technology on Advances in the Treatment of Gynecological Cancers

The rapid advancement of technology affects all aspects of our lives and alters our perspectives. In medicine, particularly in oncology and surgery, the impact of technological advances has been profound, resulting in significant breakthroughs in how patients are treated. Join Dr. Helpman as she explores some of the latest advances in the treatment of gynecologic cancers.
Dr. Limor Helpman Deputy Director of the Gynecologic Oncology Department, Sheba Medical Center  
14:23-14:38

Q&A Session

During the Q&A session, participants will be able to ask Dr. Helpman any questions they may have concerning her lecture or other clinical issues.
Dr. Limor Helpman Deputy Director of the Gynecologic Oncology Department, Sheba Medical Center  

EVENT SPEAKERS MEET SHEBA'S FINEST

Dr. Nethanel (Nati) Asher

Senior Physician at the Ella Lemelbaum Institute for Immuno-Oncology at Sheba Medical Center

Read More

Prof. Arnon Nagler

President of the Hemato-Oncology Center at Sheba Medical Center

Read More

Dr. Limor Helpman

Deputy Director of the Gynecologic Oncology Department at Sheba Medical Center

Read More

Dr. Zohar Dotan

Director of the Department of Urology and Uro-Oncology Service at Sheba Medical Center

Read More

Dr. Almog Ben-Yaacov

Attending Surgical Oncologist & Head of the Residency Training Program at the Department of Surgery and Surgical Oncology (Surgery C)

Read More

Prof. Zvi Symon

Director of the Radiation Oncology Institute at Sheba Medical Center

Read More

Why Should You Attend?

Network, connect and learn best practices from world-class clinicians and researchers belonging to one of the leading hospitals globally

Discover the latest advances in cancer care

Customize your learning experience by choosing sessions that will help solve clinical challenges relevant to you and your institution



    FAQ

    We welcome medical professionals from all parts of the world and every discipline of medicine at REACT 2021. However, the event will be most beneficial to oncologists.
    Click here for the REACT 2021 registration form, where you can reserve your spot for the conference.
    While conference participants can enjoy introductory presentations from all speakers, the keynote lectures will take place in separate breakout rooms, so you can only attend one. However, the full lectures will be uploaded to Sheba’s LinkedIn page a few days after the conference concludes.
    Please refer to our registration form, where you can both reserve your place in the conference and choose which breakout room lecture to attend
    No fee is required from REACT 2021 participants. To save your place in the conference - sign up now

    Healthcare institutions and organizations interested in registering their members to the event or promoting a future collaboration are also invited to get in touch. We will get back to you as soon as possible.

    YOU CAN ALSO FIND US ON Linkedin